|
WO1998042738A1
(en)
|
1997-03-21 |
1998-10-01 |
Human Genome Sciences, Inc. |
87 human secreted proteins
|
|
US20020137890A1
(en)
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20030054987A1
(en)
*
|
1997-06-16 |
2003-03-20 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US7160985B2
(en)
*
|
1997-10-29 |
2007-01-09 |
Genentech, Inc. |
Pro180 polypeptide
|
|
US7425613B2
(en)
|
1997-11-05 |
2008-09-16 |
Genentech, Inc. |
PRO1375 polypeptides
|
|
US20030130182A1
(en)
*
|
1997-11-05 |
2003-07-10 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US6949339B1
(en)
|
1998-05-21 |
2005-09-27 |
Diadexus, Inc. |
Method of diagnosing, monitoring, and staging colon cancer
|
|
US6623923B1
(en)
|
1998-12-23 |
2003-09-23 |
Corixa Corporation |
Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
|
|
US6914130B2
(en)
|
1998-06-17 |
2005-07-05 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
US7291712B2
(en)
|
1998-06-25 |
2007-11-06 |
Genentech, Inc. |
Interleukin-8 homologous polypeptides and therapeutic uses thereof
|
|
US7264801B2
(en)
|
1998-08-11 |
2007-09-04 |
Genentech, Inc. |
EG-VEGF nucleic acids and polypeptides and method of use
|
|
US20020172678A1
(en)
|
2000-06-23 |
2002-11-21 |
Napoleone Ferrara |
EG-VEGF nucleic acids and polypeptides and methods of use
|
|
US7507557B2
(en)
|
1998-08-17 |
2009-03-24 |
Genentech, Inc. |
Nucleic acids encoding PRO1375 polypeptides
|
|
US20030003507A1
(en)
|
1999-06-02 |
2003-01-02 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
DE69939874D1
(en)
|
1998-09-02 |
2008-12-18 |
Diadexus Inc |
METHOD OF DIAGNOSIS, EVALUATION AND IMAGE DISPLAY OF VARIOUS CANCER DISORDERS
|
|
CA2341326A1
(en)
*
|
1998-09-03 |
2000-03-16 |
Takeda Chemical Industries, Ltd. |
Novel protein and process for producing the same
|
|
US7014996B1
(en)
|
1998-10-02 |
2006-03-21 |
Diadexus, Inc. |
Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers
|
|
DE69934903T2
(en)
|
1998-11-10 |
2007-10-18 |
Emory University |
MITOGENE REGULATORS
|
|
US7888477B2
(en)
|
1998-12-17 |
2011-02-15 |
Corixa Corporation |
Ovarian cancer-associated antibodies and kits
|
|
US6670463B1
(en)
|
1998-12-17 |
2003-12-30 |
Corixa Corporation |
Compositions and methods for therapy of ovarian cancer
|
|
US20020119158A1
(en)
*
|
1998-12-17 |
2002-08-29 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
|
US6962980B2
(en)
*
|
1999-09-24 |
2005-11-08 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
|
AU2007216683B2
(en)
*
|
1998-12-17 |
2011-07-14 |
Corixa Corporation |
Compositions and methods for therapy and diagnosis of ovarian cancer
|
|
US6468546B1
(en)
|
1998-12-17 |
2002-10-22 |
Corixa Corporation |
Compositions and methods for therapy and diagnosis of ovarian cancer
|
|
US6284241B1
(en)
|
1998-12-23 |
2001-09-04 |
Corixa Corporation |
Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
|
|
CA2356987A1
(en)
*
|
1998-12-23 |
2000-06-29 |
Corixa Corporation |
Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
|
|
US20030190669A1
(en)
*
|
1998-12-30 |
2003-10-09 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
HUP0200318A2
(en)
*
|
1999-03-15 |
2002-05-29 |
Takeda Chemical Industries Ltd |
Novel proteins and uses thereof
|
|
US6797271B2
(en)
|
1999-03-25 |
2004-09-28 |
Genesis Research & Development Corporation Limited |
Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides
|
|
US6242419B1
(en)
*
|
1999-03-25 |
2001-06-05 |
Genesis Research & Development Corporation Ltd. |
Compositions isolated from stromal cells and methods for their use
|
|
EP1169445A2
(en)
*
|
1999-04-09 |
2002-01-09 |
Curagen Corporation |
Human proteins and polynucleotides encoding them
|
|
US6943235B1
(en)
|
1999-04-12 |
2005-09-13 |
Agensys, Inc. |
Transmembrane protein expressed in prostate cancer
|
|
EP1792989A1
(en)
*
|
1999-04-12 |
2007-06-06 |
Agensys, Inc. |
13 Transmembrane protein expressed in prostate cancer
|
|
US7244827B2
(en)
|
2000-04-12 |
2007-07-17 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer
|
|
AU780061B2
(en)
*
|
1999-04-12 |
2005-02-24 |
Agensys, Inc. |
Transmembrane protein expressed in prostate and other cancers
|
|
CA2374053A1
(en)
*
|
1999-05-14 |
2000-11-23 |
Curagen Corporation |
Secreted polypeptides and corresponding polynucleotides
|
|
CA2374341A1
(en)
*
|
1999-05-20 |
2000-11-30 |
Takeda Chemical Industries, Ltd. |
Novel polypeptide
|
|
AU5037100A
(en)
*
|
1999-05-27 |
2000-12-18 |
Zymogenetics Inc. |
Adipocyte complement related protein homolog zacrp6
|
|
AU3246100A
(en)
*
|
1999-06-02 |
2000-12-28 |
Genentech Inc. |
Methods and compositions for inhibiting neoplastic cell growth
|
|
CA2383254A1
(en)
*
|
1999-06-02 |
2000-12-07 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
CN100506844C
(en)
*
|
1999-07-23 |
2009-07-01 |
寒川贤治 |
Novel peptides
|
|
AU6181100A
(en)
*
|
1999-07-29 |
2001-02-19 |
Helix Research Institute |
Gene encoding novel serine protease-like protein
|
|
JP2003508030A
(en)
*
|
1999-08-11 |
2003-03-04 |
キュラジェン コーポレイション |
Novel polypeptide and nucleic acid encoding the same
|
|
EP1204681A2
(en)
*
|
1999-08-18 |
2002-05-15 |
ZymoGenetics, Inc. |
Helical cytokine zalpha48
|
|
AU7573000A
(en)
*
|
1999-09-01 |
2001-03-26 |
Genentech Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
EP1623992A3
(en)
*
|
1999-09-01 |
2006-05-10 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
JP2003531571A
(en)
*
|
1999-09-13 |
2003-10-28 |
キュラジェン コーポレイション |
Novel human proteins, polynucleotides encoding them, and methods of using them
|
|
EP1220919A2
(en)
*
|
1999-09-29 |
2002-07-10 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Metastasis-associated antigen c4.4a
|
|
DE19947010A1
(en)
*
|
1999-09-30 |
2001-04-05 |
Universitaetsklinikum Freiburg |
The PRV-1 gene and its use
|
|
GB9926532D0
(en)
*
|
1999-11-09 |
2000-01-12 |
Smithkline Beecham Biolog |
Novel compounds
|
|
WO2001034804A1
(en)
*
|
1999-11-12 |
2001-05-17 |
Lexicon Genetics Incorporated |
Human membrane proteins and polynucleotides encoding the same
|
|
US6485938B1
(en)
|
1999-11-16 |
2002-11-26 |
Zymogenetics, Inc. |
Nucleic acid molecules that encodes human Zven1
|
|
AU1608201A
(en)
*
|
1999-11-16 |
2001-05-30 |
Zymogenetics Inc. |
Human zven proteins
|
|
WO2001042466A2
(en)
*
|
1999-12-09 |
2001-06-14 |
Zymogenetics, Inc. |
Zvwf1: a member of the von willebrand factor type a domain superfamily
|
|
CA2390093A1
(en)
*
|
1999-12-10 |
2001-06-14 |
Incyte Genomics, Inc. |
Extracellular matrix and cell adhesion molecules
|
|
WO2001049716A2
(en)
*
|
1999-12-30 |
2001-07-12 |
Corixa Corporation |
Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
|
|
JP4280444B2
(en)
*
|
2000-01-06 |
2009-06-17 |
ジェネンテック・インコーポレーテッド |
Compositions and methods for inhibiting neoplastic cell growth
|
|
JP2004500818A
(en)
*
|
2000-01-28 |
2004-01-15 |
インサイト・ゲノミックス・インコーポレイテッド |
Phosphodiesterase
|
|
AU2001245371A1
(en)
|
2000-02-28 |
2001-09-12 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding
|
|
AU6802801A
(en)
*
|
2000-03-01 |
2001-09-24 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
WO2001073051A2
(en)
*
|
2000-03-24 |
2001-10-04 |
Millennium Pharmaceuticals, Inc. |
46743 and 27417, novel human acyltransferase family members and uses therefor
|
|
AU2001252940A1
(en)
|
2000-03-22 |
2001-10-03 |
Amgen Inc. |
Fibroblast growth factor receptor-like molecules and uses thereof
|
|
JP2007274956A
(en)
*
|
2006-04-05 |
2007-10-25 |
Fuso Pharmaceutical Industries Ltd |
hCL-K1 POLYPEPTIDE HAVING COLLECTIN ACTIVITY
|
|
ATE353913T1
(en)
*
|
2000-04-21 |
2007-03-15 |
Fuso Pharmaceutical Ind |
NEW COLLECTINE
|
|
WO2001083775A2
(en)
*
|
2000-05-04 |
2001-11-08 |
Incyte Genomics, Inc. |
Proteases
|
|
US6444443B1
(en)
|
2000-05-19 |
2002-09-03 |
Novartis Ag |
Gene
|
|
JP2004514651A
(en)
|
2000-05-30 |
2004-05-20 |
メルク エンド カムパニー インコーポレーテッド |
Ghrelin analogs
|
|
KR100961345B1
(en)
*
|
2000-06-23 |
2010-06-04 |
제넨테크, 인크. |
Eg-vegf nucleic acids and polypeptides and methods of use
|
|
EP1294885A2
(en)
*
|
2000-06-30 |
2003-03-26 |
Amgen, Inc. |
B7-like molecules and uses thereof
|
|
JP4965776B2
(en)
*
|
2000-07-18 |
2012-07-04 |
武田薬品工業株式会社 |
Novel bioactive peptides and uses thereof
|
|
WO2002006483A1
(en)
|
2000-07-18 |
2002-01-24 |
Takeda Chemical Industries, Ltd. |
Novel physiologically active peptide and use thereof
|
|
WO2002010187A1
(en)
*
|
2000-07-27 |
2002-02-07 |
Mayo Foundation For Medical Education And Research |
B7-h3 and b7-h4, novel immunoregulatory molecules
|
|
WO2002016581A2
(en)
*
|
2000-08-24 |
2002-02-28 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
AU2002216610A1
(en)
*
|
2000-09-01 |
2002-04-02 |
Genentech Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
WO2002036616A2
(en)
*
|
2000-10-30 |
2002-05-10 |
Diadexus, Inc. |
Compositions and methods relating to breast specific genes and proteins
|
|
JP2004532609A
(en)
*
|
2000-11-03 |
2004-10-28 |
ザ リージェント オブ ザ ユニバーシティ オブ カリフォルニア |
Prokineticin polypeptides, related compositions and methods
|
|
EP1506971A1
(en)
*
|
2000-11-03 |
2005-02-16 |
The Regents of the University of California |
Prokineticin polypeptides, related compositions and methods
|
|
WO2002052019A2
(en)
*
|
2000-12-21 |
2002-07-04 |
Millennium Pharmaceuticals, Inc. |
22437, a human sulfatase and uses therefor
|
|
US20060063230A1
(en)
|
2000-12-27 |
2006-03-23 |
Roman Naworth |
Sulfatases and methods of use thereof
|
|
EP1357187A4
(en)
*
|
2001-02-02 |
2004-12-01 |
Takeda Chemical Industries Ltd |
Novel physiologically active peptide and use thereof
|
|
US20020115136A1
(en)
*
|
2001-02-07 |
2002-08-22 |
Gennady Merkulov |
Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
|
|
EP1873245A1
(en)
*
|
2001-02-28 |
2008-01-02 |
Genentech, Inc. |
Interleukin-8 homologous polypeptides and therapeutic uses thereof
|
|
WO2002077229A2
(en)
*
|
2001-03-01 |
2002-10-03 |
Lion Bioscience Ag |
Cofactors of the liver x receptor alpha and methods of use
|
|
AU2008201044B2
(en)
*
|
2001-04-10 |
2011-07-28 |
Agensys, Inc. |
Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
|
WO2002083921A2
(en)
|
2001-04-10 |
2002-10-24 |
Agensys, Inc. |
Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
|
EP1401999A4
(en)
|
2001-05-25 |
2005-09-14 |
Amgen Inc |
B7 related protein-2 molecules and uses thereof
|
|
WO2003002737A1
(en)
*
|
2001-06-27 |
2003-01-09 |
Riken |
Novel human topoisomerase 2α inhibitory protein and utilization thereof
|
|
AU2002321768B2
(en)
*
|
2001-07-26 |
2008-03-06 |
Serono Genetics Institute S.A. |
GMG-2 polynucleotides and polypeptides and uses thereof
|
|
US7858330B2
(en)
|
2001-10-19 |
2010-12-28 |
Genentech, Inc. |
Compositions and methods for the treatment of tumor of hematopoietic origin
|
|
US7888478B2
(en)
|
2002-09-11 |
2011-02-15 |
Genentech, Inc. |
Compositions and methods for the treatment of tumor of hematopoietic origin
|
|
US20040197778A1
(en)
*
|
2002-12-26 |
2004-10-07 |
Sagres Discovery, Inc. |
Novel compositions and methods in cancer
|
|
US20030023042A1
(en)
*
|
2001-12-06 |
2003-01-30 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US7557196B2
(en)
*
|
2001-12-07 |
2009-07-07 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
hGC-1, a gene encoding a member of the olfactomedin-related protein family
|
|
US7041499B2
(en)
*
|
2001-12-12 |
2006-05-09 |
University Of North Texas Health Science Center |
Immuno activation of CS1 receptor in natural killer cells to inhibit tumor cell growth
|
|
WO2003102194A1
(en)
*
|
2002-05-31 |
2003-12-11 |
Seikagaku Corporation |
Chondroitin synthetase and dna coding for the enzyme
|
|
CA2500587A1
(en)
|
2002-10-04 |
2004-04-22 |
The Regents Of The University Of California |
Screening and therapeutic methods relating to neurogenesis
|
|
EP1558287A4
(en)
|
2002-10-07 |
2009-07-08 |
Zymogenetics Inc |
Uses of human zven antagonists
|
|
AU2003287918A1
(en)
|
2002-12-20 |
2004-07-14 |
Enkam Pharmaceuticals A/S |
Method of modulation of interaction between receptor and ligand
|
|
JP4514708B2
(en)
*
|
2003-03-06 |
2010-07-28 |
財団法人新産業創造研究機構 |
Identification and utilization of chondroitin polymerization factor
|
|
EP2526960A1
(en)
|
2003-03-12 |
2012-11-28 |
Genentech, Inc. |
Use of BV8 and/or EG-VEGF to promote hematopoiesis
|
|
US7709610B2
(en)
|
2003-05-08 |
2010-05-04 |
Facet Biotech Corporation |
Therapeutic use of anti-CS1 antibodies
|
|
US20050025763A1
(en)
|
2003-05-08 |
2005-02-03 |
Protein Design Laboratories, Inc. |
Therapeutic use of anti-CS1 antibodies
|
|
CA2525899C
(en)
|
2003-05-09 |
2016-03-08 |
Diadexus, Inc. |
Ovr110 antibody compositions and methods of use
|
|
US7544659B2
(en)
|
2004-08-13 |
2009-06-09 |
Genentech, Inc. |
Promotion of axonal regeneration
|
|
EP2230517A1
(en)
|
2005-01-07 |
2010-09-22 |
Diadexus, Inc. |
OVR110 antibody compositions and methods of use
|
|
EP1868647A4
(en)
|
2005-03-24 |
2009-04-01 |
Millennium Pharm Inc |
Antibodies that bind ov064 and methods of use therefor
|
|
WO2007067991A2
(en)
|
2005-12-08 |
2007-06-14 |
Medarex, Inc. |
Human monoclonal antibodies to o8e
|
|
AU2007325283B2
(en)
|
2006-11-27 |
2012-08-30 |
Diadexus, Inc. |
Ovr110 antibody compositions and methods of use
|
|
WO2008083239A2
(en)
|
2006-12-27 |
2008-07-10 |
The Johns Hopkins University |
Compositions and methods for stimulating an immune response
|
|
US7989173B2
(en)
|
2006-12-27 |
2011-08-02 |
The Johns Hopkins University |
Detection and diagnosis of inflammatory disorders
|
|
US9139647B2
(en)
|
2008-12-25 |
2015-09-22 |
Forerunner Pharma Research Co., Ltd. |
Diagnosis and treatment of cancer using anti-TM4SF20 antibody
|
|
AU2010286361A1
(en)
|
2009-08-31 |
2012-03-15 |
Amplimmune, Inc. |
Methods and compositions for the inhibition of transplant rejection
|
|
CN108925136B
(en)
|
2015-12-02 |
2022-02-01 |
斯特赛恩斯公司 |
Antibodies specific for glycosylated BTLA (B and T lymphocyte attenuating factor)
|
|
CN113214377B
(en)
*
|
2020-01-21 |
2022-10-28 |
四川大学 |
Antibacterial peptide AP-64 and preparation method and application thereof
|